Atalay, Selma, Juul M.P.A. van den Reek, Marisol E. Otero, Marcellus D. Njoo, Johannes M. Mommers, Paul M. Ossenkoppele, Marjolein I. Koetsier, et al. 2020. “Health Economic Consequences of a Tightly Controlled Dose Reduction Strategy for Adalimumab, Etanercept and Ustekinumab Compared With Standard Psoriasis Care: A Cost-Utility Analysis of the CONDOR Study”. Acta Dermato-Venereologica 100 (19):1-7. https://doi.org/10.2340/00015555-3692.